LAS VEGAS, Sept. 17, 2015 (GLOBE NEWSWIRE) -- QSpex is pleased to announce a strategic business relationship with Shanghai Conant Optical Ltd. ("Conant").
Under the new agreement, QSpex will continue to supplement its same-day range of products and services with Conant's complementary range of products. In addition, both companies will share new and existing product development and manufacturing infrastructure, under protective licensing terms, to aid in the development of new products to be offered through the QSpex-Conant Partnership. Together, they will develop, launch, market, and operate an integrated model to deliver a unique and comprehensive same-day offering in addition to complementary optical lenses for a more extensive, bundled approach. The collaboration will enable QSpex and Conant to continue to serve traditional markets and channels, and allow for the expansion into nationally and globally scaled retail channels as well as emerging and underserved geographies.
"As QSpex enters new markets, channels and territories, we will continue to seek out strong partners like Conant to ensure our mutual success," said Brett Craig, QSpex's Chief Executive Officer. "Both companies have agreed upon general roles and responsibilities and relationship standards to leverage one another's key assets. Bringing together QSpex's advanced technology and exceptional services with Conant's trusted lens manufacturing capabilities will help customers realize the full benefits of QSpex lenses and utilize our unique services for a competitive advantage."
"As one of QSpex's most integrated partners, Conant brings a unique ability to understand the business impact of QSpex technologies and services," said Dr. Frank Fei, Conant's Chief Executive Officer. "As this relationship accelerates, Conant and QSpex expect to develop and launch a series of new technological advancements that challenge industry standards."
QSpex's mission is to offer consumers premium prescription eyewear with same-day, delivery and dispensing at locations of choice; while giving eye care providers the unique capability to increase patient satisfaction through the quality of the lens and lens treatments, and providing delivery on the same day the eye exam is performed. QSpex was founded in 2007 based on proprietary technology created by Dr. Kai Su, Founder and Chief Science Officer. Dr. Su, an industry technology veteran, served as the Executive Vice President and Head of Research for CIBA Vision's Advanced Technology Division and has invented over 100 vision care patents. Brett Craig, the President and CEO since 2013, has over 15 years of experience in the eye care industry, including his previous role as the President and Chief Operating Officer of Transitions Optical. He is responsible for redirecting the strategy and operations of the Company. For more information about QSpex, please visit us online at www.qspex.com.
CONTACT: Kelsey Berry 770-442-5314 email@example.com
Source: QSpex Technologies